NCT01416883View on ClinicalTrials.gov

Oral Mucosal Absorption Study of Bicalutamide New Formulation

PHASE1TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Healthy

Interventions

DRUG

ICI176,334-1

Subject will receive single dose of ICI176,334-1

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY